Alzheimer's & Cognition

Transdermal rivastigmine for dementia

Transdermal formulation may reduce side effects, making optimal dosing easier.

Early intervention helps protect patients from lasting harm

Rapid memory loss, visual hallucinations, recent stroke differentiate vascular, Lewy body subtypes

Author:: Harold W. Goforth, MD; Amity Ruth, PhD; Chirag R. Ravel, MD; Murali S. Rao, MD

Ms. A, age 83, is increasingly confused and agitated. She attacks caregivers and distrusts her friends at church. The challenge: diagnose her...

Author:: John W. Kasckow, MD, PhD; Jeffrey J. Mulchahey, PhD; Somaia Mohamed, MD, PhD

Careful dosing of atypicals plus psychosocial interventions can safely manage agitation and psychotic behavior

NMDA receptor antagonist targets functioning, is well-tolerated, and may be combined with cholinesterase inhibitors.

Mrs. S, 85, is showing signs of cognitive impairment. Is depression or dementia causing her forgetfulness? Treatment decisions made now will...

Three cholinesterase inhibitors—donepezil, rivastigmine, and galantamine—are commonly used to treat Alzheimer’s disease. How effective are they in...